跳至主要内容
临床试验/IRCT20220424054633N1
IRCT20220424054633N1招募中3 期

?Comparison of efficacy of Silversulfadiazine topical cream containing Epidermal growth factor (EGF) and Silversulfadiazine topical cream without Epidermal growth factor (EGF) on burn wounds healing (type II).

Tehran University of Medical Sciences0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • People with grade II burn wounds.
  • Burn area must be bilateral, in 2 hands or 2 legs, etc.

排除标准

  • Having any underlying diseases that interfere with wound healing such as chronic kidney disease, diabetes, liver disease, any diseases of immunodeficiency, and smoking.
  • Having cancer or background of Cancer
  • Allergy to Epidermal Growth Factor, silver sulfadiazin or any material in the formulation.
  • Breastfeeding

研究者

相似试验

The efficacy assessment of Silversulfadiazine... | 临床试验